ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Return on Assets

Nxera Pharma Co., Ltd. (4565)

Market cap
¥94.6B
P/E ratio
Nexera Pharma discovers, develops and commercializes innovative specialty pharmaceuticals to improve patient quality of life in Japan and worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Dec 31, 2025-8.7+179.55%
Dec 31, 2024-3.1-44.21%
Dec 31, 2023-5.6-1538.46%
Dec 31, 20220.4-66.67%
Dec 31, 20211.2-47.30%
Dec 31, 20202.2-2.20%
Dec 31, 20192.3-120.34%
Dec 31, 2018-11.2+147.45%
Mar 31, 2018-4.5-122.29%
Mar 31, 201720.2-783.45%
Mar 31, 2016-3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat